Elaborate
PrivateLast Round
Seed
Jan 26, 2023
Total Funding Raised
$10M
Company Overview
Elaborate operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in January 2023.
Elaborate is a healthtech company that provides a clinical intelligence platform to automate inbox workflows and contextualize patient communications for healthcare practitioners.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, EHR & EMR, Workflow Automation, NLP & Conversational AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elaborate Comparables
Compare Elaborate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affineon Health | 85% | |
| Droxi | 85% | |
| Switchboard, MD | 81% |
For institutional investors. Book with your work email.
Elaborate Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Elaborate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Founder Collective | Seed |
| Company Ventures | Seed |
| Company Ventures | Seed |
| Tusk Venture Partners | Seed |
| Arkitekt Ventures | Seed |
| Bling Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2026
Added Northwestern Medical Group, an enterprise healthcare organization, as a customer.
- Sep 16, 2025
Added Millennium Physician Group, a healthcare company, as a customer.
For institutional investors. Book with your work email.
Elaborate Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elaborate's valuation, stock price, and market status.
Is Elaborate a public or private company?
Elaborate is a private company.
What is the current stock price of Elaborate?
Elaborate is a private company, so its shares have no public market price. Caplight tracks Elaborate's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elaborate worth (valuation)?
Valuation information for Elaborate is not publicly available.
Can I buy Elaborate stock?
Elaborate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elaborate's last funding round?
Elaborate's most recent funding round was Seed on January 26, 2023.
Who are the main investors in Elaborate?
Key investors in Elaborate include Tusk Venture Partners.
Will Elaborate IPO soon?
No public IPO plans have been announced for Elaborate.
How can I track Elaborate secondary market activity?
Caplight tracks bids, offers, and trades in Elaborate's shares on secondary markets.